| Literature DB >> 14667220 |
Xiaoming Li1, Sam Chu, Victoria A Feher, Mitra Khalili, Zhe Nie, Stephen Margosiak, Victor Nikulin, James Levin, Kelly G Sprankle, Martina E Tedder, Robert Almassy, Krzysztof Appelt, Kraig M Yager.
Abstract
The structure-based design, synthesis, and biological activity of a novel indazole-containing inhibitor series for S-adenosyl homocysteine/methylthioadenosine (SAH/MTA) nucleosidase are described. Use of 5-aminoindazole as the core scaffold provided a structure-guided series of low nanomolar inhibitors with broad-spectrum antimicrobial activity. The implementation of structure-based methodologies provided a 6000-fold increase in potency over a short timeline (several months) and an economy of synthesized compounds.Entities:
Mesh:
Substances:
Year: 2003 PMID: 14667220 DOI: 10.1021/jm0302039
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446